Linder Nehama, Tallen-Gozani Esther, German Boris, Duvdevani Poriya, Ferber Asaf, Sirota Lea
Department of Neonatology, Schneider Children's Medical Center of Israel, Petah Tivka.
Vaccine. 2004 Mar 29;22(11-12):1509-14. doi: 10.1016/j.vaccine.2003.10.009.
Despite nationwide measles vaccination coverage in Israel of over 90%, repeated outbreaks of measles have spread from isolated communities with poor immunization uptake. Some severely affected individuals were children under 1 year of age, including premature infants. We evaluated the serological status of 195 newborn infants and their 161 mothers divided into four groups: vaccinated mothers (VMs) and premature infants, VM and full term infants, naturally immunized mothers (NIMs) and premature infants, NIM and full term infants. Maternal and cord blood measles antibody titers were determined by haemagglutination inhibition (HI) test and microneutralization test (mNT). Fewer than 40% of preterm infants of VM and less then 70% of preterm infants of NIM had protective titers at birth. The results of this study may aid in formulating new measles vaccination recommendations for preterm infants.
尽管以色列全国麻疹疫苗接种覆盖率超过90%,但麻疹疫情仍反复从免疫接种率低的孤立社区蔓延开来。一些受严重影响的个体是1岁以下儿童,包括早产儿。我们评估了195名新生儿及其161名母亲的血清学状况,将其分为四组:接种疫苗的母亲(VMs)和早产儿、VM和足月儿、自然免疫的母亲(NIMs)和早产儿、NIM和足月儿。通过血凝抑制(HI)试验和微量中和试验(mNT)测定母体和脐带血麻疹抗体滴度。VM组的早产儿中出生时具有保护性滴度的不到40%,NIM组的早产儿中这一比例不到70%。本研究结果可能有助于为早产儿制定新的麻疹疫苗接种建议。